Induction of protective immune response against Streptococcus suis serotype 2 infection by the surface antigen HP0245

FEMS Microbiology Letters

Volumn 316, Issue 2, 2011, Pages 115-122

  Li, Wei ^a   Hu, Xueying ^a   Liu, Lei ^a   Chen, Huanchun ^a   Zhou, Rui ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Extracellular peptide; HP0245; Streptococcus suis serotype 2; Vaccine candidate

Indexed keywords

ADJUVANT; ALUMINUM HYDROXIDE; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIAL VACCINE; BACTERIN; IMMUNOGLOBULIN G2; PEPTIDE; PROTEIN HP 0245; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; BACTERIAL STRAIN; CELL SURFACE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNITY; IMMUNOGENICITY; IN VIVO STUDY; LETTER; MENINX; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN LOCALIZATION; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS SUIS; SURVIVAL RATE; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; FEMALE; HUMANS; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS SUIS;

ESCHERICHIA COLI; MUS; STREPTOCOCCUS SUIS;

EID: 79951773820     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2010.02200.x     Document Type: Letter

References (30)

1. Aranda J, Garrido ME, Cortes P, Llagostera M & Barbe J (2008) Analysis of the protective capacity of three Streptococcus suis proteins induced under divalent-cation-limited conditions. Infect Immun 76: 1590-1598.
2. Baums CG, Kock C, Beineke A, Bennecke K, Goethe R, Schröder C, Waldmann K & Valentin-Weigand P (2009) Streptococcus suis bacterin and subunit vaccine immunogenicities and protective efficacies against serotypes 2 and 9. Clin Vaccine Immunol 16: 200-208.
3. Benga L, Fulde M, Neis C, Goethe R & Valentin-Weigand P (2008) Polysaccharide capsule and suilysin contribute to extracellular survival of Streptococcus suis co-cultivated with primary porcine phagocytes. Vet Microbiol 132: 211-219.
4. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
5. Chen B, Zhang A, Li R, Mu X, He H, Chen H & Jin M (2010) Evaluation of the protective efficacy of a newly identified immunogenic protein, HP0272, of Streptococcus suis. FEMS Microbiol Lett 307: 12-18.
6. Chen C, Tang J, Dong W et al. (2007) A glimpse of streptococcal toxic shock syndrome from comparative genomics of S. suis 2 Chinese isolates. PLoS One 2: e315.
7. Geng HR, Zhu L, Yuan Y et al. (2008) Identification and characterization of novel immunogenic proteins of Streptococcus suis serotype 2. J Proteome Res 7: 4132-4142.
8. Gottschalk M & Segura M (2000) The pathogenesis of the meningitis caused by Streptococcus suis: the unresolved questions. Vet Microbiol 76: 259-272.
9. Haesebrouck F, Pasmans F, Chiers K, Maes D, Ducatelle R & Decostere A (2004) Efficacy of vaccines against bacterial diseases in swine: what can we expect? Vet Microbiol 100: 255-268.
10. Halbur P, Thanawongnuwech R, Brown G, Kinyon J, Roth J, Thacker E & Thacker B (2000) Efficacy of antimicrobial treatments and vaccination regimens for control of porcine reproductive and respiratory syndrome virus and Streptococcus suis coinfection of nursery pigs. J Clin Microbiol 38: 1156-1160.
11. Holden MTG, Hauser H, Sanders M et al. (2009) Rapid evolution of virulence and drug resistance in the emerging zoonotic pathogen Streptococcus suis. PLoS One 4: e6072.
12. Hu Q, Liu P, Yu Z, Zhan G, Li J, Teng L, Zhou M, Bei W, Chen H & Jin M (2009) Identification of a cell wall-associated subtilisin-like serine protease involved in the pathogenesis of Streptococcus suis serotype 2. Microb Pathogenesis 48: 103-109.
13. Jacobs AA, Loeffen PL, van den Berg AJ & Storm PK (1996) Identification, purification, and characterization of a thiol-activated hemolysin (suilysin) of Streptococcus suis. Infect Immun 62: 1742-1748.
14. Li W, Liu L, Qiu D, Chen H & Zhou R (2010) Identification of Streptococcus suis serotype 2 genes preferentially expressed in the natural host. Int J Med Microbiol 300: 482-488.
15. Li Y, Gottschalk M, Esgleas M, Lacouture S, Dubreuil JD, Wilson P & Harel J (2007) Immunization with recombinant Sao protein confers protection against Streptococcus suis infection. Clin Vaccine Immunol 14: 937-943.
16. Liu L, Cheng G, Wang CJ, Pan XZ, Cong YG, Pan Q, Wang J, Zheng F, Hu FQ & Tang JQ (2009) Identification and experimental verification of protective antigens against Streptococcus suis serotype 2 based on genome sequence analysis. Curr Microbiol 58: 11-17.
17. Lun ZR, Wang QP, Chen XG, Li AX & Zhu XQ (2007) Streptococcus suis: an emerging zoonotic pathogen. Lancet Infect Dis 7: 201-209.
18. Okwumabua O & Chinnapapakkagari S (2005) Identification of the gene encoding a 38-kilodalton immunogenic and protective antigen of Streptococcus suis. Clin Diagn Lab Immun 12: 484-490.
19. Pallares FJ, Schmitt CS, Roth JA, Evans RB, Kinyon JM & Halbur PG (2004) Evaluation of a ceftiofur-washed whole cell Streptococcus suis bacterin in pigs. Can J Vet Res 68: 236-240.
20. Sambrook J & Russell DW (2006) Purification of expressed proteins from inclusion bodies. Cold Spring Harb Protoc 1: 4089.
21. Smith HE, Buijs H, de Vries R, Wisselink HJ, Stockhofe-Zurwieden N & Smits MA (2001) Environmentally regulated genes of Streptococcus suis: identification by the use of iron-restricted conditions in vitro and by experimental infection of piglets. Microbiology 147: 271-280.
22. Tan C, Liu M, Liu J, Yuan F, Fu S, Liu Y, Jin M, Bei W & Chen H (2009) Vaccination with Streptococcus suis serotype 2 recombinant 6PGD protein provides protection against S. suis infection in swine. FEMS Microbiol Lett 296: 78-83.
23. Wei Z, Li R, Zhang A, He H, Hua Y, Xia J, Cai X, Chen H & Jin M (2009) Characterization of Streptococcus suis isolates from the diseased pigs in China between 2003 and 2007. Vet Microbiol 137: 196-201.
24. Wertheim HF, Nghia HD, Taylor W & Schultsz C (2009) Streptococcus suis: an emerging human pathogen. Clin Infect Dis 48: 617-625.
25. Wisselink HJ, Smith HE, Stockhofe-Zurwieden N, Peperkamp K & Vecht U (2000) Distribution of capsular types and production of muramidase-released protein (MRP) and extracellular factor (EF) of Streptococcus suis strains isolated from diseased pigs in seven European countries. Vet Microbiol 74: 237-248.
26. Wisselink HJ, Vecht U, Stockhofe-Zurwieden N & Smith HE (2001) Protection of pigs against challenge with virulent Streptococcus suis serotype 2 strains by a muramidase-released protein and extracellular factor vaccine. Vet Rec 148: 473-477.
27. Ye C, Zheng H, Zhang J et al. (2009) Clinical, experimental, and genomic differences between intermediately pathogenic, highly pathogenic, and epidemic Streptococcus suis. J Infect Dis 199: 97-107.
28. Zhang A, Xie C, Chen H & Jin M (2008) Identification of immunogenic cell wall-associated proteins of Streptococcus suis serotype 2. Proteomics 8: 3506-3515.
29. Zhang A, Chen B, Li R, Mu X, Han L, Zhou H, Chen H & Jin M (2009a) Identification of a surface protective antigen, HP0197 of Streptococcus suis serotype 2. Vaccine 27: 5209-5213.
30. Zhang A, Chen B, Mu X, Li R, Zheng P, Zhao Y, Chen H & Jin M (2009b) Identification and characterization of a novel protective antigen, Enolase of Streptococcus suis serotype 2. Vaccine 27: 1348-1353.